1. Stocks
    2. /
  2. Acadia Pharmaceuticals (NASDAQ: ACAD)
    3. /

Acadia Pharmaceuticals (NASDAQ: ACAD) Share Price and News

$21.54 $-1.03 (-4.6%) 11 April 2026 at 4:10:23 am AEST

Acadia Pharmaceuticals Chart and Price Data

About Acadia Pharmaceuticals

Last updated 11-04-2026, 04:10:23am AEST
Current Price $21.54
Change $-1.03 (-4.6%)
Close Price $22.57
Open Price $22.59
Bid $21.53
Ask $21.55
Day Range $21.42 - $22.60
Year Range $13.73 - $28.35
Volume 409,142
Average Volume 1,688,165
Market Cap $3,848,072,200.00
Earnings Per Share $2.29

    • Acadia Pharmaceuticals (NASDAQ: ACAD)
    Latest News

    Ecstatic man giving a fist pump in an office hallway.
    Healthcare Shares

    Why Neuren shares are rebounding on Wednesday after a brutal 2026 sell-off

    | Aaron Teboneras

    Neuren shares jump after DAYBUE STIX expands across the US.

    Read more »

    A young man punches the air in delight as he reacts to great news on his mobile phone.
    Broker Notes

    Why this cheap ASX 200 stock could rise 80%

    | James Mickleboro

    Bell Potter thinks this stock could be destined to surge.

    Read more »

    A worried man holds his head and look at his computer.
    Share Fallers

    Why Capstone Copper, Life360, Neuren, and St George Mining shares are falling today

    | James Mickleboro

    These shares are out of form and sinking into the red on Tuesday. Let's find out why.

    Read more »

    A man sitting at his desktop computer leans forward onto his elbows and yawns while he rubs his eyes as though he is very tired.
    Healthcare Shares

    Why is this ASX 200 stock sinking 6% today?

    | James Mickleboro

    This stock is having a tough session. Let's find out what's going on.

    Read more »

    A man pulls a shocked expression with mouth wide open as he holds up his laptop.
    Healthcare Shares

    ASX 200 healthcare stock sinks 9% on FDA update

    | James Mickleboro

    Let's see what this stock has announced on Thursday.

    Read more »

    A man sitting at a computer is blown away by what he's seeing on the screen, hair and tie whooshing back as he screams argh in panic.
    Healthcare Shares

    Guess which ASX 200 healthcare share is crashing 22% on Tuesday on European blow

    | James Mickleboro

    Bad news out of Europe is weighing heavily on this stock today.

    Read more »

    Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
    Healthcare Shares

    This ASX 200 stock is charging higher on FDA approval news

    | James Mickleboro

    This stock is avoiding the market weakness on Monday. Let's find out why.

    Read more »

    A woman presenting company news to investors looks back at the camera and smiles.
    Small Cap Shares

    These ASX small cap shares could be tomorrow's blue chips

    | James Mickleboro

    Analysts think these small caps could be great picks right now.

    Read more »

    Shot of a senior scientist looking stressed out while working in a lab.
    Healthcare Shares

    Why did this $1.4 billion ASX 200 healthcare stock just dive 9%?

    | Sebastian Bowen

    The market didn't like what this stock had to say this morning...

    Read more »

    Happy shareholders clap and smile as they listen to a company earnings report.
    Share Gainers

    Why Brainchip, Cooper Energy, Core Lithium, and Neuren shares are roaring higher today

    | James Mickleboro

    These shares are having a good time on hump day. But why?

    Read more »

    Successful group of people applauding in a business meeting and looking very happy.
    Share Gainers

    2 ASX 200 shares rising on big news

    | James Mickleboro

    What's getting investors excited today? Let's find out.

    Read more »

    A young boy sits on his father's shoulders as they flex their muscles at sunrise on a beach
    Investing Strategies

    $10k of savings? I'd buy these ASX 200 shares to grow my money

    | Tony Yoo

    I would choose the stocks based on whether the company seems likely to be doing better in five years' time…

    Read more »

    Profile

    since

    Note